Last reviewed · How we verify
NCT03957785
Lower Body Positive Pressure Treadmill Training in Post-Stroke Gait Impairment
NA trial testing AlterG Treatment in Gait, Hemiplegic in 75 participants. Completed in 31 May 2018.
31 January 2018
Quick facts
| Lead sponsor | IRCCS Centro Neurolesi Bonino Pulejo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 June 2017 |
| Primary completion | 31 January 2018 |
| Estimated completion | 31 May 2018 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- AlterG Treatment
Conditions studied
- Gait, Hemiplegic — all drugs for Gait, Hemiplegic →
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo — full company profile →
Who can join
55 and older, any sex, with Gait, Hemiplegic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lower body positive pressure (LBPP) decreases weight bearing and ground reaction forces, with potentially positive effects on qualitative gait indices. However, which gait features are shaped by LBPP gait training in post-stroke patients is still poorly predictable. A pilot study on the effects of LBPP gait training on qualitative and quantitative gait indices in patients with hemiparesis due to stroke in the chronic phase was carried out. Twenty-five patients who suffered from a first, single, ischemic, supra-tentorial stroke occurred at least 6 months before study inclusion were provided with 24 daily sessions of LBPP treadmill gait training using AlterG device. These patients were compared with 25 age-matched healthy controls (HC), who were formerly provided with the same amount of AlterG training, and 25 patients with the same clinical-demographic characteristics of the first group of patients, who previously underwent conventional treadmill gait training (TGT). Qualitative and quantitative gait features, including Functional Ambulation Categories, gait cycle features, and muscle activation patterns were analyzed before and after the training (AlterG or TGT).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03957785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gait, Hemiplegic
Currently open trials in the same condition.
- NCT06845709 — Effects of Otago and Gaze Stabilization Exercises on Balance, Gait and QOL in Elderly Stroke Patients · NA · recruiting
- NCT06543758 — Effectiveness and Safety of At-home Gait Rehabilitation Using Wearable Exoskeletal Robot · Phase 4 · recruiting
- NCT06327035 — Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center · recruiting
- NCT05740540 — Implant for Walking After Stroke · NA · recruiting
- NCT05908149 — Gait Analysis in Patients With Hemiplegia Using Insole Splint. · NA · recruiting
Other IRCCS Centro Neurolesi Bonino Pulejo trials
Trials by the same sponsor.
- NCT07385508 — Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Si · not yet recruiting
- NCT07358962 — Mild Cognitive Impairment and Psychopathology · not yet recruiting
- NCT07321080 — Central Sensitisation in Nociceptive and Neuropathic Pain · active not recruiting
- NCT07268768 — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE · recruiting
- NCT07422324 — Multidimensional Assessment of Mental Health in Adolescence. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Centro Neurolesi Bonino Pulejo
- Last refreshed: 22 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing